Racura Executive Director on Disrupt Radio

Racura Executive Director on Disrupt Radio

07/18/24

Racura Executive Director on Disrupt Radio

Racura Oncology Executive Director Dr Peter Smith joined Disrupt Radio to discuss building biotech businesses in Australia, what to look out for when investing in biotech businesses, and why Racura’s lead drug bisantrene is...

What’s In Store For 2024: Racura Oncology

02/05/24

What’s In Store For 2024: Racura Oncology

2024 Preview: Racura Oncology (ASX:RAC) from Stockhead on Vimeo. Stockhead’s Ashtyn Hiron sits down with Racura Oncology (ASX:RAC) CEO Daniel Tillett to close the books on 2023 and gain a sneak peek into what’s around the corner. The clinical stage...

Racura Oncology
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.